These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2192959)

  • 1. [Luteinizing hormone-releasing hormone agonists for treatment of prostatic cancer].
    Gez E
    Harefuah; 1990 Apr; 118(8):483-6. PubMed ID: 2192959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
    Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
    Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical progress with LHRH analogues in prostatic cancer. Proceedings of an international symposium. Monte Carlo, 20 January 1990.
    J Int Med Res; 1990; 18 Suppl 1():1-125. PubMed ID: 2108881
    [No Abstract]   [Full Text] [Related]  

  • 4. Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art.
    Schally AV
    BJU Int; 2007 Jul; 100 Suppl 2():2-4. PubMed ID: 17594347
    [No Abstract]   [Full Text] [Related]  

  • 5. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
    Garnick MB; Glode LM; Smith JA; Max DT
    Br J Clin Pract; 1985 Feb; 39(2):73-6. PubMed ID: 3921047
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term experience in the treatment of advanced prostatic cancer with decapeptyl, compared to orchiectomy.
    De Sy WA; De Wilde P; De Meyer JM; Casselman J; Desmet R; Renders G; Schelfhout W
    Acta Urol Belg; 1988; 56(4):581-8. PubMed ID: 2974680
    [No Abstract]   [Full Text] [Related]  

  • 7. Initiation of LHRH monotherapy for prostate cancer.
    Milsted RA
    Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal therapy for prostate cancer.
    Torti FM
    N Engl J Med; 1984 Nov; 311(20):1313-4. PubMed ID: 6436701
    [No Abstract]   [Full Text] [Related]  

  • 9. [Luteinizing hormone-releasing hormone agonists for treatment of breast cancer].
    Gez E; Kovner F
    Harefuah; 1990 Jun; 118(11):655-8. PubMed ID: 2143745
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of metastatic carcinoma of the prostate with leuprolide, an LHRH analogue.
    Smith JA
    Prog Clin Biol Res; 1985; 185A():279-85. PubMed ID: 3929267
    [No Abstract]   [Full Text] [Related]  

  • 11. Decapeptyl in the treatment of advanced prostatic cancer: comparative study with pulpectomy.
    Botto H; Richard F; Mathieu F; Camey M
    Prog Clin Biol Res; 1989; 303():53-60. PubMed ID: 2528740
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma].
    Gez E; Ben-Yosef R; Libson E; Biran S
    Harefuah; 1987 Mar; 112(5):239-41. PubMed ID: 3301586
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of a long acting luteinizing hormone releasing hormone agonist (Decapeptyl) and orchiectomy in the treatment of advanced prostatic cancer. Preliminary report.
    De Sy WA; de Meyer JM; Casselman J; De Smet R; Renders G; Schelfhout W; De Wilde P
    Acta Urol Belg; 1986; 54(2):221-9. PubMed ID: 2942015
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F; Dupont A; Belanger A
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract]   [Full Text] [Related]  

  • 15. [LHRH analogs--new possibilities in the treatment of prostatic cancer].
    Baranowska B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1009-12. PubMed ID: 6239145
    [No Abstract]   [Full Text] [Related]  

  • 16. [Zoladex in prostatic carcinoma].
    Di Silverio F; Serio M
    Drugs Exp Clin Res; 1990; 16 Suppl():19-29. PubMed ID: 2150501
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and maintenance of castration by an LHRH analogue: D-Trp6 LHRH or decapeptyl.
    Fretin J; Demerle F; Jardin A
    Prog Clin Biol Res; 1987; 243A():245-7. PubMed ID: 2958855
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the chronic administration of LH-RH agonist on the oral glucose tolerance test in patients with prostatic carcinoma.
    González-Bárcena D; Pérez-Sánchez P; Hernández-Meza AR; Rangel-García N; Graef-Sánchez A; Comaru-Schally AM; Schally AV
    Arch Invest Med (Mex); 1987; 18(4):273-8. PubMed ID: 2969222
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of a powerful luteinizing hormone releasing hormone analogue agonist and estrogen in the treatment of advanced prostatic cancer.
    Winfield H; Trachtenberg J
    J Urol; 1984 Jun; 131(6):1107-9. PubMed ID: 6427477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.